Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 19;56(3):137.
doi: 10.3390/medicina56030137.

Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches

Giovanni Schepici  1 , Serena Silvestro  1 , Placido Bramanti  1 , Emanuela Mazzon  1
Affiliations
Review

Traumatic Brain Injury and Stem Cells: An Overview of Clinical Trials, the Current Treatments and Future Therapeutic Approaches

Giovanni Schepici et al. Medicina (Kaunas). .

Abstract

Traumatic brain injury represents physical damage to the brain tissue that induces transitory or permanent neurological disabilities. The traumatic injury activates an important inflammatory response, followed by a cascade of events that lead to neuronal loss and further brain damage. Maintaining proper ventilation, a normal level of oxygenation, and adequate blood pressure are the main therapeutic strategies performed after injury. Surgery is often necessary for patients with more serious injuries. However, to date, there are no therapies that completely resolve the brain damage suffered following the trauma. Stem cells, due to their capacity to differentiate into neuronal cells and through releasing neurotrophic factors, seem to be a valid strategy to use in the treatment of traumatic brain injury. The purpose of this review is to provide an overview of clinical trials, aimed to evaluate the use of stem cell-based therapy in traumatic brain injury. These studies aim to assess the safety and efficacy of stem cells in this disease. The results available so far are few; therefore, future studies need in order to evaluate the safety and efficacy of stem cell transplantation in traumatic brain injury.

Keywords: clinical studies; inflammation; stem cell transplantation; stem cells; traumatic brain injury.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dewan M.C., Rattani A., Gupta S., Baticulon R.E., Hung Y.C., Punchak M., Agrawal A., Adeleye A.O., Shrime M.G., Rubiano A.M., et al. Estimating the global incidence of traumatic brain injury. J. Neurosurg. 2018;130:1080–1097. doi: 10.3171/2017.10.JNS17352. - DOI - PubMed
    1. Arciniegas D.B., Held K., Wagner P. Cognitive impairment following traumatic brain injury. Curr. Treat. Options Neurol. 2002;4:43–57. doi: 10.1007/s11940-002-0004-6. - DOI - PubMed
    1. Irrera N., Pizzino G., Calo M., Pallio G., Mannino F., Fama F., Arcoraci V., Fodale V., David A., Francesca C., et al. Lack of the nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front. Pharmacol. 2017;8:459. doi: 10.3389/fphar.2017.00459. - DOI - PMC - PubMed
    1. Picetti E., Rossi S., Abu-Zidan F.M., Ansaloni L., Armonda R., Baiocchi G.L., Bala M., Balogh Z.J., Berardino M., Biffl W.L., et al. Wses consensus conference guidelines: Monitoring and management of severe adult traumatic brain injury patients with polytrauma in the first 24 h. World J. Emerg. Surg. WJES. 2019;14:53. doi: 10.1186/s13017-019-0270-1. - DOI - PMC - PubMed
    1. Capizzi A., Woo J., Verduzco-Gutierrez M. Traumatic brain injury: An overview of epidemiology, pathophysiology, and medical management. Med. Clin. N. Am. 2020;104:213–238. doi: 10.1016/j.mcna.2019.11.001. - DOI - PubMed

MeSH terms

Substances

Grants and funding